James E. Wagner Cultivation Corporation Receives Second Pre-Approval for Save on Energy Incentive Program
James E. Wagner Cultivation (JWC) (TSXV:JWCA) (OTCQX: JWCAF), is pleased to announce on April 10, 2019, it received its second pre-approval for the Save on Energy incentive program (the “Incentive”) for its highly efficient, state-of-the-art, retrofit climate control systems. The received pre-approval extends to include three applications; one for each pod within the Phase 2 development of production rooms at JWC’s second site facility, JWC 2, on Manitou Drive in Kitchener, ON. The Incentive is funded through the Independent Electricity System Operator (“IESO”).
“JWC is thrilled to receive its pre-approval for all three Save on Energy applications for Phase 2 of JWC 2. This pre-approval is a culmination of months of effort and collaboration, as we continue to produce clean consistent cannabis through the adoption of state-of-the-art technologies. We firmly believe this pre-approval establishes a new benchmark for energy-conscious environmental control in the industry,” said William Werth, Chief Technology Officer of James E. Wagner Cultivation.
JWC expects to install a total of six state-of-the-art GRW HVAC units at the JWC 2 facility to accommodate the three pods of the Phase 2 flowering rooms. Each of the pods consist of approximately 12,000 square feet, comprising the Phase 2 stage of the JWC 2 build-out. Recognizing that the cannabis industry is highly energy-intensive, the Company has made it a priority to develop an environmentally conscious and energy efficient production process. The six upcoming GRW HVAC units are in addition to the already installed three units serving the completed Phase 1 production space. JWC also has one unit installed at its pilot facility, JWC 1, located at 855 Trillium Drive in Kitchener. With the implementation of these six new GRW HVAC units in Phase 2, JWC will achieve advanced micro-climate environmental control at a significantly reduced consumption of energy. This achievement will positively impact production yields and reduce the time required to complete a plant growth lifecycle.
The Incentive is structured to reimburse up to 50% of JWC’s HVAC infrastructure costs. In order to be eligible for final approval and receipt of the financial Incentive value, JWC will be required to concurrently complete a twelve-month Measurement and Verification (“M&V”) periods, for each of the three pods within Phase 2. The three M&V periods will commence once the pod construction is complete and the pods have been commissioned for cultivation activities. The M&V period measures energy consumption to ensure that the GRW HVAC units are functioning at the projected level of energy-efficiency. JWC has worked closely with Kitchener-Wilmot Hydro Inc. on this project to ensure that the greatest potential environmental benefits will be achieved.
Kitchener-Wilmot Hydro Inc. anticipates the energy efficiency of each pod within Phase 2 will save an estimated 2,973,216-kilowatt hours (“kWh”) annually. The estimated savings represents an approximate equivalency to the energy consumed by more than 930 homes in the Region of Waterloo. With the aid of the Save on Energy incentive program, JWC can effectively measure energy savings, continue to optimize the energy efficiency of its operation, and receive a substantial return on investment.
About James E. Wagner Cultivation Corporation
JWC’s wholly-owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary Dual Droplet™ aeroponic platform named GrowthSTORM™. JWC was founded as a family company and is based on family values. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca.
Notice regarding forward-looking statements:
This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include, among other things, statements regarding JWC and any collaboration with the GRW HVAC manufacturer, including the development of and completion of any research, technology, or patents, and any statements regarding JWC, Kitchener-Wilmot Hydro Inc., and the Save on Energy incentive program, and the effect on plant production yields and plant lifecycle durations. The forward-looking statements can be identified by the use of such words as “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, building permit related risks and risks associated with growth and competition as well as the risks identified in the Company’s Filing Statement available under the Company’s profile at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information about this release, please contact
Nathan Woodworth, President & CEO of JWC
Phone: (519) 594-0144 x421
George Aizpurua, Vice President of First Canadian Capital Corp.
Phone: (416) 742-5600
Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:
Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.